Related Experiment Video
Updated: Aug 8, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Antiphospholipid antibodies, ischemic stroke in young adults, and calcium supplementation: a hypothesis
J Newmark1, H L Newmark, L A Marden
1Neurology Service, Madigan Army Medical Center, Tacoma, WA, USA.
Insights
This study suggests adding calcium and vitamin D supplements to anticoagulant therapy for younger ischemic stroke patients with antiphospholipid antibodies. This combined approach may offer additive benefits for stroke prevention.
Area of Science:
- Neurology
- Hematology
- Nutritional Science
Background:
- Ischemic stroke in young adults lacking traditional risk factors presents a treatment challenge.
- Antiphospholipid antibodies are a key risk factor in these patients.
- Current standard treatment involves anticoagulant therapy, but optimal adjunctive strategies are debated.
Observation:
- The optimal treatment strategy for ischemic stroke in young patients with antiphospholipid antibodies remains unclear.
- Dietary supplementation with calcium and vitamin D is proposed as an adjunct therapy.
Findings:
- The study hypothesizes that calcium and vitamin D supplementation will provide additive benefits to standard anticoagulant therapy.
- This hypothesis requires validation through large-scale clinical trials.
Implications:
- Investigating combined therapy could lead to improved stroke management protocols for affected patients.
- The military health care system's infrastructure is suitable for conducting such extensive research.
- Establishing the efficacy of this combined approach may enhance patient recovery and reduce stroke recurrence.
Abstract:
The proper treatment of younger patients who have suffered ischemic stroke and who have no stroke risk factors other than antiphospholipid antibodies is unsettled. We propose a rationale to support adding dietary supplementation with calcium and vitamin D to the present standard regimen of anticoagulant therapy for these patients. We expect that the benefits from this additional therapy will prove additive. Proving this hypothesis will require large numbers of patients unlikely to present to any one center. The military health care system is well suited to such a study.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Atherosclerosis III: Management
Peripheral Artery Disease I: Introduction
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction

